Anxiety and depression as well as the domination of functional neurologic symptoms were characteristic of patients with atypical facial pain. Anxiolytic and antidepressive effects of noophen were seen from the 21st day of treatment. A mild stimulation effect and sleep normalization were also observed. An improvement of the mental state was found in 70% patients with atypical facial pain in the end of treatment: 50% patients demonstrated a significant improvement.
Представлен обзор литературы по исследованию невралгической головной боли с вегетативными проявлениями. Невралгическая головная боль с вегетативными проявлениями является первичной головной болью с фенотипом тригеминальной боли, сопровождающейся слезотечением, ринореей, покраснением конъюнктивы. Рассматриваются вопросы классификации, патогенеза, клинической картины, диагностики и лечения этой формы головной боли. Особое внимание уделено кластерной головной боли, пароксизмальной гемикрании, SUNCT-синдрому, постоянной гемикрании.
Ключевые слова: невралгическая головная боль с вегетативными проявлениями, кластерная головная боль, пароксизмаль-ная гемикрания, SUNCT-синдром, постоянная гемикрания.Rewiew of literature on the trigeminal autonomic cephalgias are presented. Trigeminal autonomic cephalgias are primary headaches with phenotype consisting of trigeminal pain with autonomic signs including lacrimation, rhinorrhoea and miosis. Discussed are issues of classification, pathogenesis, clinical picture, diagnosis, differential diagnosis and treatment of this headache. Special attention is paid to cluster headache, paroxysmal hemicrania, SUNCT syndrome, hemicrania continua.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.